Prescription pattern for pregnant and lactating mothers, and attitude towards the safety of medicines in a tertiary hospital in Bangladesh
Keywords:Pregnancy, Lactation, Drug utilization, Safety, Perception
Background: Prescription pattern of drugs particularly in the special physiological conditions, e.g., pregnancy and lactation have an impact on the mothers as well as the newborns. More specifically, the evaluation of the pattern can play a pivotal role to minimize their economic burden as well as improving their quality of life by reducing drug related toxicity. This study aims at the evaluation of the prescription pattern for the pregnant and lactating mothers for the first time in one of the largest tertiary hospitals in Bangladesh. Moreover, the perception of the patients about the safety of the medicines has also been enlightened.
Methods: Data collected from 500 pregnant women and 335 lactating mothers were analyzed in the context of demographic characteristics, drug use pattern, USFDA drug risk category, and clinical complications to understand their attitude towards the safety of medicines.
Results: The study suggests that the majority of the participants were aware of the safety and usage of medications during pregnancy and lactation. Moreover, the linear regression analysis clearly indicates that pregnant women were significantly associated with a higher attitude score compared to that of the lactating mothers.
Conclusions: This study necessitates the requirement to implement the relevant WHO recommended core interventions and to develop a healthcare system by incorporating clinical pharmacists about the dispensing and sale of medicines in ensuring the rational use of medicines more efficiently.
Begg EJ. Prescribing in pregnancy and lactation. Br J Clin Pharmacol. 2008;65(5):627-628.
Alemu BK, Wolle NN. Prescription drug use and potential teratogenicity risk among pregnant women attending maternal and child health clinic of Kemisse General Hospital, Northeast, Ethiopia. BMC Res Notes. 2019;12(1):1-15.
Malm H, Martikainen J, Klaukka T, Neuvonen PJ. Prescription drugs during pregnancy and lactation - A Finnish register-based study. Eur J Clin Pharmacol. 2003;59(2):127-133.
Zhang J, Ung COL, Wagner AK, Guan X, Shi L. Medication use during pregnancy in mainland china: A cross-sectional analysis of a national health insurance database. Clin Epidemiol. 2019;11:1057-65.
Bedewi N, Sisay M, Edessa D. Drug utilization pattern among pregnant women attending maternal and child health clinic of tertiary hospital in eastern Ethiopia: Consideration of toxicological perspectives. BMC Res Notes. 2018;11(1):1-7.
Anitha B, Malavika S, Kumar B, Ramesh Y. Current trends in drugs avoided in pregnancy. J Drug Deliv Ther. 2018;8(6):342-350.
Era N, Mukherjee S. Drug usage in pregnancy in an out-patient department in Biomedical European of AND Pharmaceutical sciences drug usage in pregnancy in an out-patient department in tertiary; 2019.
Andrade SE, Raebel MA, Morse AN. Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf. 2006;15(8):546-54.
Egen-Lappe V, Hasford J. Drug prescription in pregnancy: Analysis of a large statutory sickness fund population. Eur J Clin Pharmacol. 2004;60(9):659-66.
Wen SW, Yang T, Krewski D. Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population. J Perinatol. 2008;28(5):324-9.
Yadav S, Evangeline SG. A Study on Prescribing Patterns of Drugs in Pregnant Women Attending a Teaching Hospital. Int J Pharmacol Ther. 2016;9(1):9-26.
Zaki NM, Albarraq AA. Use, attitudes and knowledge of medications among pregnant women: A Saudi study. Saudi Pharm J. 2014;22(5):419-28.
Agarwal M, Nayeem M, Safhi MM, Gupta N, Makeen HA, Sumaily JM. Prescribing pattern of drugs in the department of obstetrics and gynecology in expected mothers in Jazan Region, KSA. Int J Pharm Pharm Sci. 2014;6(1):658-61.
Principles G. Guidelines for the Prescribing of Medication during Lactation; 2012. Available at: http://www.nyrdtc.nhs.uk/Services/teratology/teratology.html.
Sukumaran D, Cherian AG, Das S, Winston AB, Kumar A, Shanthi FXM. Drug prescribing pattern during intra-natal period in a secondary care hospital in South India: A retrospective study. J Prim Care Community Heal. 2016;7(2):113-7.
Miah MM, Mridha SA, Rayhan AM, Ferdous A. A Study of Prescribing Pattern of Drugs during Pregnancy and Lactation in the Secondary and Tertiary Care Hospitals of Bangladesh: A Cross Sectional Study. Am J Pharmacol Toxicol. 2017;12(4):68-78.
Olesen C, Steffensen FH, Nielsen GL. Drug use in first pregnancy and lactation: A population-based survey among Danish women. Eur J Clin Pharmacol. 1999;55(2):139-144.
Olesen C, Sorensen HT, De Jong-Van Den Berg L. Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women. Acta Obstet Gynecol Scand. 1999;78(8):686-92.
Henderson A. Safe prescribing practices in pregnancy and lactation. J Midwifery Women’s Heal. 2003;48(2):162.
Rohra DK, Das N, Azam SI. Drug-prescribing patterns during pregnancy in the tertiary care hospitals of Pakistan: A cross sectional study. BMC Pregnancy Childbirth. 2008;8:1-5.
Gajic A, Herrmann R, Salzberg M. The international quality requirements for the conduct of clinical studies and the challenges for study centers to implement them. Ann Oncol. 2004;15(9):1305-9.
Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121-6.
Nielsen GL, Nørgard B, Puho E, Rothman KJ, Sørensen HT, Czeizel AE. Risk of specific congenital abnormalities in offspring of women with diabetes. Diabet Med. 2005;22(6):693-6.
Desalegn AA. Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopia: A cross-sectional study. BMC Health Serv Res. 2013;13(1).
Maats F, Crowther C. Patterns of vitamin, mineral and herbal supplement use prior to and during pregnancy. Aust New Zeal J Obstet Gynaecol. 2002;42(5):494-6.